A new organization of endocrinologists, focused on reducing complications from diabetes, has been formed. The Council for the Advancement of Diabetes Research and Education (CADRE) is underwritten by joint unrestricted educational grants from Aventis Pharmaceuticals Inc. and Pfizer Inc. Both firms offer diabetes therapies.
CADRE begins life with a survey of endocrinologists that suggests a re-evaluation of diabetes treatment algorithm. Eighty-one percent of endocrinologists who specia